TTAB Oppositions 91274813
USPTO Oppositions proceeding 91274813, filed 2022-03-02. Status: Terminated.
Proceeding Facts
| Proceeding Number | 91274813 |
|---|---|
| Type | Oppositions |
| Status | Terminated |
| Filing Date | 2022-03-02 |
| Last Activity | 2022-06-21 |
| Days Active | 1535 |
Parties
- Amphastar Pharmaceuticals, Inc. — Defendant
- Mylan, Inc. — Plaintiff
Plaintiff Marks
- EPILOCKER — Mylan, Inc.
- EPIPEN — Mylan, Inc.
- EPIPEN — Mylan, Inc.
- EPIPEN — Mylan, Inc.
- EPIPEN 2-PAK — Mylan, Inc.
- EPIPEN4SCHOOLS — Mylan, Inc.
- EPIPEN (EPINEPHRINE INJECTION) AUTO-INJECTORS 0.3 MG EPIPEN JR (EPINEPHRINE INJECTION) AUTO-INJECTORS 0.15 MG — Mylan, Inc.
- EPIPEN (EPINEPHRINE INJECTION) AUTO-INJECTORS 0.3MG EPIPEN JR (EPINEPHRINE INJECTION) AUTO-INJECTORS 0.15MG — Mylan, Inc.
- EPIPEN EPIPEN JR (EPINEPHRINE INJECTION) AUTO-INJECTORS 0.3/0.15 MG — Mylan, Inc.
- EPIPEN JR — Mylan, Inc.
- EPIPEN JR. 2-PAK — Mylan, Inc.
- MY EPIPEN — Mylan, Inc.
- MY EPIPEN SAVINGS CARD — Mylan, Inc.
- MY EPIPLAN — Mylan, Inc.
Defendant Marks
- NASEPI — Amphastar Pharmaceuticals, Inc.
Recent Documents
- 2022-06-21: TERMINATED — Status
- 2022-06-21: BD DECISION: OPP SUSTAINED — Decisions
- 2022-04-22: NOTICE OF DEFAULT — Defaults
- 2022-03-02: INSTITUTED — Status
- 2022-03-02: NOTICE AND TRIAL DATES SENT; ANSWER DUE: — Scheduling
- 2022-03-02: FILED AND FEE — Fees